Literature DB >> 20062906

Efficacy of infliximab on the acute attack of uveitis.

Fahdah Alokaily1, Sulaiman Alsaleh, Maryseon Al-Balawi, Seham Al-Rashidi.   

Abstract

Uveitis is one of the major features of behcet's disease with relapse and remission pattern. Severe presentation can be resistant to the conventional treatment. Steroid has been used in the treatment of acute behcet's uveitis, although it especially has its own ocular complications when used in large doses. We describe to patients presented with acute uveitis while on treatment, uveitis was controlled by adding anti-tumor necrosis factor (TNF) and Infliximab.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20062906

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  4 in total

Review 1.  Update on the therapy of Behçet disease.

Authors:  Zeinab Saleh; Thurayya Arayssi
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

Review 2.  [Off-label use of infliximab].

Authors:  M Onder; C Salavastru; K Fritz
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751

3.  Etanercept therapy in Behçet's disease. The tight control strategy in refractory disease.

Authors:  R H A Mohammed
Journal:  Z Rheumatol       Date:  2014-09       Impact factor: 1.372

4.  Efficacy of infliximab in refractory Behçet's disease-associated and idiopathic posterior segment uveitis: a prospective, follow-up study of 50 patients.

Authors:  Fabrizio Cantini; Laura Niccoli; Carlotta Nannini; Olga Kaloudi; Emanuele Cassarà; Massimo Susini; Ivo Lenzetti
Journal:  Biologics       Date:  2011-12-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.